Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.

被引:54
作者
Al-Mariri, A
Tibor, A
Mertens, P
De Bolle, X
Michel, P
Godfroid, JK
Walravens, K
Letesson, J
机构
[1] Fac Univ Notre Dame Paix, Lab Immunol & Microbiol, URBM, B-5000 Namur, Belgium
[2] CERVA, B-1180 Brussels, Belgium
关键词
D O I
10.1128/IAI.69.10.6264-6270.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study, we evaluated the ability of DNA vaccines encoding the bacterioferritin (BFR) or P39 proteins of Brucella spp. to induce cellular and humoral immune responses and to protect BALB/c mice against a challenge with B. abortus 544. We constructed eukaryotic expression vectors called pCIBFR and pCIP39, encoding BFR or P39 antigens, respectively, and we verified that these proteins were produced after transfection of COS-7 cells. PCIBFR or pCIP39 was injected intramuscularly three times, at 3-week intervals. pCIP39 induced higher antibody responses than did the DNA vector encoding BFR. Both vectors elicited a T-cell-proliferative response and also induced a strong gamma interferon production upon restimulation with either the specific antigens or Brucella extract. In this report, we also demonstrat that animals immunized with these plasmids elicited a strong and long-lived memory immune response which persisted at least 3 months after the third vaccination. Furthermore, pCIBFR and pCIP39 induced a typical T-helper 1-dominated immune response in mice, as determined by cytokine or immunoglobulin G isotype analysis. The pCIP39 delivered by intramuscular injection (but not the pCIBFR or control vectors) induced a moderate protection in BALB/c mice challenged with B. abortus 544 compared to that observed in positive control mice vaccinated with S19.
引用
收藏
页码:6264 / 6270
页数:7
相关论文
共 63 条
[1]   DNA vaccination: Transfection and activation of dendritic cells as key events for immunity [J].
Akbari, O ;
Panjwani, N ;
Garcia, S ;
Tascon, R ;
Lowrie, D ;
Stockinger, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :169-177
[2]   Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant [J].
Al-Mariri, A ;
Tibor, A ;
Mertens, P ;
De Bolle, X ;
Michel, P ;
Godefroid, J ;
Walravens, K ;
Letesson, JJ .
INFECTION AND IMMUNITY, 2001, 69 (08) :4816-4822
[3]  
ARAYA LN, 1989, J IMMUNOL, V143, P3330
[4]  
Baldwin C L, 1994, Immunol Ser, V60, P363
[5]  
Caron E, 1996, J IMMUNOL, V156, P2885
[6]   LIVE BRUCELLA SPP FAIL TO INDUCE TUMOR-NECROSIS-FACTOR-ALPHA EXCRETION UPON INFECTION OF U937-DERIVED PHAGOCYTES [J].
CARON, E ;
PEYRARD, T ;
KOHLER, S ;
CABANE, S ;
LIAUTARD, JP ;
DORNAND, J .
INFECTION AND IMMUNITY, 1994, 62 (12) :5267-5274
[7]  
CHEVILLE NF, 1993, AM J VET RES, V54, P1591
[8]   Recent advances in brucellosis [J].
Corbel, MJ .
JOURNAL OF MEDICAL MICROBIOLOGY, 1997, 46 (02) :101-103
[9]   Gene vaccination with naked plasmid DNA: Mechanism of CTL priming [J].
Corr, M ;
Lee, DJ ;
Carson, DA ;
Tighe, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1555-1560
[10]   Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection [J].
Denis, O ;
Tanghe, A ;
Palfliet, K ;
Jurion, F ;
van den Berg, TP ;
Vanonckelen, A ;
Ooms, J ;
Saman, E ;
Ulmer, JB ;
Content, J ;
Huygen, K .
INFECTION AND IMMUNITY, 1998, 66 (04) :1527-1533